Amyloids

Friend or foe?

Neal D. Hammer, Xuan Wang, Bryan A. McGuffie, Matthew R. Chapman

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Amyloidogenesis is the aggregation of soluble proteins into structurally conserved fibers. Amyloid fibers are distinguished by their resistance to proteinase K, tinctorial properties and β-sheet-rich secondary structure. Amyloid formation is a hallmark of many human diseases including Alzheimer's, Huntington's and the prion diseases. Therefore, understanding amyloidogenesis will provide insights into the development of therapeutics that target these debilitating diseases. A new class of 'functional' amyloids promises a unique glimpse at how nature has harnessed the amyloid fiber to accomplish important physiological tasks. Functional amyloids are produced by organisms spanning all aspects of cellular life. Herein we review amyloidogenesis, with special attention focused on the similarities and differences between the best characterized disease-associated amyloidogenic protein amyloid-β and the formation of several functional amyloids. The implications of studying functional amyloidogenesis and the strategies organisms employ to limit exposure to toxic intermediates will also be discussed.

Original languageEnglish (US)
Pages (from-to)407-419
Number of pages13
JournalJournal of Alzheimer's Disease
Volume13
Issue number4
StatePublished - 2008
Externally publishedYes

Fingerprint

Amyloid
Amyloidogenic Proteins
Endopeptidase K
Prion Diseases
Poisons
Huntington Disease
Alzheimer Disease
Staining and Labeling
Proteins

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

Hammer, N. D., Wang, X., McGuffie, B. A., & Chapman, M. R. (2008). Amyloids: Friend or foe? Journal of Alzheimer's Disease, 13(4), 407-419.

Amyloids : Friend or foe? / Hammer, Neal D.; Wang, Xuan; McGuffie, Bryan A.; Chapman, Matthew R.

In: Journal of Alzheimer's Disease, Vol. 13, No. 4, 2008, p. 407-419.

Research output: Contribution to journalArticle

Hammer, ND, Wang, X, McGuffie, BA & Chapman, MR 2008, 'Amyloids: Friend or foe?', Journal of Alzheimer's Disease, vol. 13, no. 4, pp. 407-419.
Hammer ND, Wang X, McGuffie BA, Chapman MR. Amyloids: Friend or foe? Journal of Alzheimer's Disease. 2008;13(4):407-419.
Hammer, Neal D. ; Wang, Xuan ; McGuffie, Bryan A. ; Chapman, Matthew R. / Amyloids : Friend or foe?. In: Journal of Alzheimer's Disease. 2008 ; Vol. 13, No. 4. pp. 407-419.
@article{d0b36eca9e214710b1a99c2966584157,
title = "Amyloids: Friend or foe?",
abstract = "Amyloidogenesis is the aggregation of soluble proteins into structurally conserved fibers. Amyloid fibers are distinguished by their resistance to proteinase K, tinctorial properties and β-sheet-rich secondary structure. Amyloid formation is a hallmark of many human diseases including Alzheimer's, Huntington's and the prion diseases. Therefore, understanding amyloidogenesis will provide insights into the development of therapeutics that target these debilitating diseases. A new class of 'functional' amyloids promises a unique glimpse at how nature has harnessed the amyloid fiber to accomplish important physiological tasks. Functional amyloids are produced by organisms spanning all aspects of cellular life. Herein we review amyloidogenesis, with special attention focused on the similarities and differences between the best characterized disease-associated amyloidogenic protein amyloid-β and the formation of several functional amyloids. The implications of studying functional amyloidogenesis and the strategies organisms employ to limit exposure to toxic intermediates will also be discussed.",
author = "Hammer, {Neal D.} and Xuan Wang and McGuffie, {Bryan A.} and Chapman, {Matthew R.}",
year = "2008",
language = "English (US)",
volume = "13",
pages = "407--419",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Amyloids

T2 - Friend or foe?

AU - Hammer, Neal D.

AU - Wang, Xuan

AU - McGuffie, Bryan A.

AU - Chapman, Matthew R.

PY - 2008

Y1 - 2008

N2 - Amyloidogenesis is the aggregation of soluble proteins into structurally conserved fibers. Amyloid fibers are distinguished by their resistance to proteinase K, tinctorial properties and β-sheet-rich secondary structure. Amyloid formation is a hallmark of many human diseases including Alzheimer's, Huntington's and the prion diseases. Therefore, understanding amyloidogenesis will provide insights into the development of therapeutics that target these debilitating diseases. A new class of 'functional' amyloids promises a unique glimpse at how nature has harnessed the amyloid fiber to accomplish important physiological tasks. Functional amyloids are produced by organisms spanning all aspects of cellular life. Herein we review amyloidogenesis, with special attention focused on the similarities and differences between the best characterized disease-associated amyloidogenic protein amyloid-β and the formation of several functional amyloids. The implications of studying functional amyloidogenesis and the strategies organisms employ to limit exposure to toxic intermediates will also be discussed.

AB - Amyloidogenesis is the aggregation of soluble proteins into structurally conserved fibers. Amyloid fibers are distinguished by their resistance to proteinase K, tinctorial properties and β-sheet-rich secondary structure. Amyloid formation is a hallmark of many human diseases including Alzheimer's, Huntington's and the prion diseases. Therefore, understanding amyloidogenesis will provide insights into the development of therapeutics that target these debilitating diseases. A new class of 'functional' amyloids promises a unique glimpse at how nature has harnessed the amyloid fiber to accomplish important physiological tasks. Functional amyloids are produced by organisms spanning all aspects of cellular life. Herein we review amyloidogenesis, with special attention focused on the similarities and differences between the best characterized disease-associated amyloidogenic protein amyloid-β and the formation of several functional amyloids. The implications of studying functional amyloidogenesis and the strategies organisms employ to limit exposure to toxic intermediates will also be discussed.

UR - http://www.scopus.com/inward/record.url?scp=44949181936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949181936&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 407

EP - 419

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -